Skip to content

SCHEDULE 13GAccepted Feb 4, 4:31 PM ET

Enveric Biosciences, Inc. SCHEDULE 13G

Lind Global Fund III LP

Accepted (ET)

4:31 PM

Feb 4, 2026

Filed

Feb 4, 2026

Documents

2

Size

17.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.